FDA authorizes booster shots of Pfizer-BioNTech’s COVID-19 vaccine for 16- and 17-year-olds. Booster doses are already encouraged for people over 18 who had their previous Pfizer-BioNTech or Moderna vaccines at least six months earlier or the Johnson & Johnson shot at least two months ago. Source 8h.
FDA authorization is on hold for Pfizer's COVID vaccine for kids under 5 as companies wait for more data. Pfizer and BioNTech pushed the pause button Friday on the process of authorizing its COVID-19 vaccine for the youngest children, saying they want to wait until data becomes available on a third vaccine dose for children under 5, likely in early April. Source 2c.
Pfizer says its COVID booster shot for kids ages 5 to 11 is safe and spurs a strong immune response. Healthy children ages 5 to 11 mount a safe, strong immune response to the Pfizer-BioNTech COVID-19 booster, according to a new study from the companies. Pfizer and BioNTech said they will ask the Food and Drug Administration to authorize booster shots for the 5-11 age group. Source 9v.